Spike Medicine 22
  • Home

  • About Us

      • Company Profile

      • Enterprise culture

      • Qualification Honor

      • Chairman's Speech

  • News

      • Company Dynamics

      • Industry dynamics

  • Recruitment

  • Contact Us

      • Contact Information

      • Online message

  • Home

  • About Us

    • Company Profile

    • Enterprise culture

    • Qualification Honor

    • Chairman's Speech

  • News

    • Company Dynamics

    • Industry dynamics

  • Recruitment

  • Contact Us

    • Contact Information

    • Online message

+86-579-82131973
中文
NEWS

Jul 11,2022

The State Food and Drug Administration issued the Regulations on the Administration of Vaccine Production and Circulation


In order to implement the requirements of laws and regulations such as the the People's Republic of China Drug Administration Law and the the People's Republic of China Vaccine Administration Law, build a scientific and effective vaccine production and circulation supervision and management system, and regulate the production and circulation management activities of vaccines in accordance with the characteristics of vaccine products and vaccine supervision requirements, the State Food and Drug Administration has organized and formulated the regulations on the Administration of Vaccine production and Circulation, which are hereby promulgated and shall come into force as of the date of promulgation.

Key words:

The State Food and Drug Administration issued the Regulations on the Administration of Vaccine Production and Circulation

Sep 22,2022

New targets for pan-cancer, new directions for medicine!


In recent years, despite the hype surrounding adoptive T-cell therapies in the biopharmaceutical industry, it remains a challenge to find therapeutic targets that are consistent across different tumor types and are not expressed in healthy cells. Recently, a team of scientists from the University of Pennsylvania and immunotherapy drug development biotechnology company Immatics have identified an antigen component from 11 different solid tumor patient tissues, which is expected to provide new breakthroughs in the development of T cell therapies.

Key words:

New targets for pan-cancer, new directions for medicine!

Oct 13,2022

Jianfeng Pharmaceutical was invited to participate in the Shanghai Pharmaceutical Fair.


From September 20 to 22, the 85th National Drug Fair was solemnly held in Shanghai National Convention and Exhibition Center. Jianfeng Pharmaceutical Company brought many new products to the exhibition.

Key words:

Jianfeng Pharmaceutical was invited to participate in the Shanghai Pharmaceutical Fair.
< 1...58596061 >
contact Contact
tel +86-579-82131973
tel gs@zjifyy.com.cn
Whatsapp
top TOP
Chenglian Medicine

Follow us

  • Home

  • About Us

    • Company Profile

    • Enterprise culture

    • Qualification Honor

    • Chairman's Speech

  • News

    • Company Dynamics

    • Industry dynamics

  • Recruitment

  • Contact Us

    • Contact Information

    • Online message

Zhejiang Jianfeng Pharmaceutical Co., Ltd.

Sales Line:

+86-579-82131973
Mailbox:gs@zjifyy.com.cn
Company address: No.88, Wujiang East Road, Jinhua City, Zhejiang Province

Copyright©2023 Zhejiang Jianfeng Pharmaceutical Co., Ltd

Powered by www.300.cn | SEO  | Business License

SAF Coolest v1.3.1.1 设置面板XRBSX-ZEJN-JAAZE-ZWD

图片ALT信息: JIANFENG

无数据提示

Sorry, the current column is being updated, please look forward to it!

You can view other columns or returnHome Page